Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.
2.

Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography.

Perry DC, Xiao Y, Nguyen HN, Musachio JL, Dávila-García MI, Kellar KJ.

J Neurochem. 2002 Aug;82(3):468-81.

4.

α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.

Marks MJ, Grady SR, Salminen O, Paley MA, Wageman CR, McIntosh JM, Whiteaker P.

J Neurochem. 2014 Jul;130(2):185-98. doi: 10.1111/jnc.12721. Epub 2014 Apr 19.

5.
6.

Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.

Mugnaini M, Garzotti M, Sartori I, Pilla M, Repeto P, Heidbreder CA, Tessari M.

Neuroscience. 2006;137(2):565-72. Epub 2005 Nov 14.

PMID:
16289885
7.

Effect of repeated nicotine exposure on high-affinity nicotinic acetylcholine receptor density in spontaneously hypertensive rats.

Hohnadel EJ, Hernandez CM, Gearhart DA, Terry AV Jr.

Neurosci Lett. 2005 Jul 1-8;382(1-2):158-63. Epub 2005 Apr 1.

PMID:
15911141
8.

Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.

Metaxas A, Al-Hasani R, Farshim P, Tubby K, Berwick A, Ledent C, Hourani S, Kitchen I, Bailey A.

Neuropharmacology. 2013 Aug;71:228-36. doi: 10.1016/j.neuropharm.2013.03.023. Epub 2013 Apr 11.

PMID:
23583933
10.

Protracted treatment with MDMA induces heteromeric nicotinic receptor up-regulation in the rat brain: an autoradiography study.

Ciudad-Roberts A, Camarasa J, Pubill D, Escubedo E.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Aug 4;53:1-8. doi: 10.1016/j.pnpbp.2014.02.014. Epub 2014 Mar 12.

PMID:
24614096
11.

The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo.

Mao D, Perry DC, Yasuda RP, Wolfe BB, Kellar KJ.

J Neurochem. 2008 Jan;104(2):446-56. Epub 2007 Oct 24.

12.

Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.

Flores CM, Dávila-García MI, Ulrich YM, Kellar KJ.

J Neurochem. 1997 Nov;69(5):2216-9.

13.
14.

Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain.

Marks MJ, Smith KW, Collins AC.

J Pharmacol Exp Ther. 1998 Apr;285(1):377-86.

15.

AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.

Toll L, Zaveri NT, Polgar WE, Jiang F, Khroyan TV, Zhou W, Xie XS, Stauber GB, Costello MR, Leslie FM.

Neuropsychopharmacology. 2012 May;37(6):1367-76. doi: 10.1038/npp.2011.322. Epub 2012 Jan 25.

16.

Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotine.

Bordia T, Parameswaran N, Fan H, Langston JW, McIntosh JM, Quik M.

J Pharmacol Exp Ther. 2006 Oct;319(1):285-92. Epub 2006 Jul 12.

17.

Nicotine-induced alterations in the expression of nicotinic receptors in primary cultures from human prenatal brain.

Hellström-Lindahl E, Seiger A, Kjaeldgaard A, Nordberg A.

Neuroscience. 2001;105(3):527-34.

PMID:
11516820
18.
19.

Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.

Marks MJ, O'Neill HC, Wynalda-Camozzi KM, Ortiz NC, Simmons EE, Short CA, Butt CM, McIntosh JM, Grady SR.

Neuropharmacology. 2015 Dec;99:142-55. doi: 10.1016/j.neuropharm.2015.07.019. Epub 2015 Jul 17.

20.

Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation.

McCallum SE, Collins AC, Paylor R, Marks MJ.

Psychopharmacology (Berl). 2006 Mar;184(3-4):314-27. Epub 2005 Jul 2.

PMID:
16001112

Supplemental Content

Support Center